2 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 2 separate news trends connected to Regeneron, spanning June 29, 2026 through August 11, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 21 article observations and 20 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Alameda-based biotech Infinimmune has secured $75 million in Series A funding to advance its antibody pipeline for atopic dermatitis and inflammatory diseases.
The FDA is launching a pilot program to accelerate the review process for new pharmaceutical manufacturing facilities, starting with Eli Lilly and Regeneron.